Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating Activities
Net income (loss)	$ 1,579,776	$ 356,711	$ (192,947)
Adjustments to reconcile net income (loss) to operating activities:
Amortization, depreciation and write-offs	448,680	489,008	547,084
Stock-based compensation, excluding cash-settled awards	369,367	363,107	191,612
Impairment of investments	0	27,953	0
Loss on settlement of debt	28,375	4,337	0
Change in operating right-of-use assets	12,689	17,842	17,107
Amortization of debt issuance costs and discount	5,460	9,363	12,678
Loss on disposal of long-lived assets	1,646	0	127,892
Other	2,557	1,863	1,786
Changes in operating assets and liabilities:
Accounts receivable	(467,028)	(261,279)	(174,829)
Prepaid expenses and other current assets	4,056	(12,280)	(3,725)
Other assets	(189,387)	(121,688)	(77,343)
Accounts payable	189,585	98,574	3,479
Operating lease liabilities	(14,106)	(18,612)	(18,898)
Accrued and other liabilities	133,974	92,754	(6,412)
Deferred revenue	(6,633)	13,857	(14,711)
Net cash provided by operating activities	2,099,011	1,061,510	412,773
Investing Activities
Acquisitions of businesses and intangible assets	(25,553)	(63,899)	(1,345,776)
Purchase of non-marketable equity securities	(76,983)	(17,934)	(66,342)
Purchase of property and equipment	(4,776)	(4,246)	(662)
Proceeds from sale of assets and other	558	8,250	41,312
Net cash used in investing activities	(106,754)	(77,829)	(1,371,468)
Financing Activities
Principal repayments of debt	(4,225,223)	(497,994)	(25,810)
Payments of withholding taxes related to net share settlement	(1,143,525)	(246,435)	(27,535)
Repurchases of common stock	(981,297)	(1,153,593)	(338,880)
Payments of deferred acquisition costs	0	(33,903)	(124,184)
Payments of licensed asset obligation	0	(27,110)	(17,374)
Payments of debt issuance cost	(35,563)	(4,655)	0
Principal payments of finance leases	(20,875)	(20,170)	(24,083)
Proceeds from issuance of debt	4,614,841	395,281	0
Proceeds from issuance of common stock upon exercise of stock options and purchase of ESPP shares	41,798	25,788	31,018
Net cash used in financing activities	(1,749,844)	(1,562,791)	(526,848)
Effect of foreign exchange rate on cash, cash equivalents, and restricted cash equivalents	(3,154)	778	(4,477)
Net (decrease) increase in cash, cash equivalents, and restricted cash equivalents	239,259	(578,332)	(1,490,020)
Cash, cash equivalents, and restricted cash equivalents at beginning of the period	502,152	1,080,484	2,570,504
Cash and cash equivalents at end of the period	741,411	502,152	1,080,484
Supplemental non-cash investing and financing activities disclosures:
Right-of-use assets acquired under finance leases	20,874	113,440	46,108
Right-of-use assets acquired under operating leases	5,451	6,471	7,105
Accrued withholding taxes related to net share settlement of restricted stock units	8,606	0	0
Issuance of common stock and common stock warrants in connection with acquisitions	0	0	137,422
Acquisitions not yet paid	0	0	31,045
Assets acquired not yet paid	510	0	33,566
Proceeds from sale of long-lived assets not yet received	0	0	7,000
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	67,332	75,433	86,264
Cash paid for interest	$ 270,615	$ 248,828	$ 165,959